CannaPharmaRx Valuation
| CPMD Stock | USD 0.01 0.00 0.00% |
CannaPharmaRx seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of CannaPharmaRx from analyzing the firm fundamentals such as Shares Owned By Insiders of 1.12 %, current valuation of 20.13 M, and Return On Equity of -2.51 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that CannaPharmaRx's price fluctuation is out of control at this time. Calculation of the real value of CannaPharmaRx is based on 3 months time horizon. Increasing CannaPharmaRx's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CannaPharmaRx pink sheet is determined by what a typical buyer is willing to pay for full or partial control of CannaPharmaRx. Since CannaPharmaRx is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CannaPharmaRx Pink Sheet. However, CannaPharmaRx's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0078 | Real 0.006678 | Hype 0.01 | Naive 0.008145 |
The real value of CannaPharmaRx Pink Sheet, also known as its intrinsic value, is the underlying worth of CannaPharmaRx Company, which is reflected in its stock price. It is based on CannaPharmaRx's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CannaPharmaRx's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of CannaPharmaRx helps investors to forecast how CannaPharmaRx pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CannaPharmaRx more accurately as focusing exclusively on CannaPharmaRx's fundamentals will not take into account other important factors: CannaPharmaRx Total Value Analysis
CannaPharmaRx is currently expected to have valuation of 20.13 M with market capitalization of 2.83 M, debt of 14.96 M, and cash on hands of 5.18 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the CannaPharmaRx fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
20.13 M | 2.83 M | 14.96 M | 5.18 K |
CannaPharmaRx Asset Utilization
One of the ways to look at asset utilization of CannaPharmaRx is to check how much profit was generated for every dollar of assets it reports. CannaPharmaRx shows a negative utilization of assets of -0.26 percent, losing $0.002554 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of CannaPharmaRx shows how discouraging it operates for each dollar spent on its assets.CannaPharmaRx Ownership Allocation
CannaPharmaRx holds a total of 257.57 Million outstanding shares. Almost 98.88 percent of CannaPharmaRx outstanding shares are held by general public with 1.12 (percent) owned by insiders and only 0.0 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.CannaPharmaRx Profitability Analysis
Net Loss for the year was (8.83 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CannaPharmaRx's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CannaPharmaRx and how it compares across the competition.
About CannaPharmaRx Valuation
The pink sheet valuation mechanism determines CannaPharmaRx's current worth on a weekly basis. Our valuation model uses a comparative analysis of CannaPharmaRx. We calculate exposure to CannaPharmaRx's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CannaPharmaRx's related companies.CannaPharmaRX, Inc. operates in the cannabis industry in Canada. The company was incorporated in 1998 and is based in Calgary, Canada. Cannapharmarx operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.
8 Steps to conduct CannaPharmaRx's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CannaPharmaRx's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CannaPharmaRx's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CannaPharmaRx's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CannaPharmaRx's revenue streams: Identify CannaPharmaRx's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CannaPharmaRx's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CannaPharmaRx's growth potential: Evaluate CannaPharmaRx's management, business model, and growth potential.
- Determine CannaPharmaRx's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CannaPharmaRx's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
CannaPharmaRx Growth Indicators
Investing in growth stocks can be very risky. If the company such as CannaPharmaRx does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 40.7 M | |
| Retained Earnings | -86.2 M |
Complementary Tools for CannaPharmaRx Pink Sheet analysis
When running CannaPharmaRx's price analysis, check to measure CannaPharmaRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannaPharmaRx is operating at the current time. Most of CannaPharmaRx's value examination focuses on studying past and present price action to predict the probability of CannaPharmaRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannaPharmaRx's price. Additionally, you may evaluate how the addition of CannaPharmaRx to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |